Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation
Journal article published in 2017 by
J. Schrader,
F. O. Henes,
D. Perez,
S. Burdak-Rothkamm 
,
A. Stein,
J. R. Izbicki,
A. W. Lohse
,
A. Stein,
J. R. Izbicki,
A. W. Lohse
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 